PV Bulletin

Qu Feng Huo Lou Dan May Be Harmful Due to Hidden Ingredient

The FDA advises against the purchase or use of Qu Feng Huo Lou Dan due to harmful hidden ingredient.

Primary source: form

PV Impact Brief

Urgency: HighConfidence: high

What changed

The FDA has issued a consumer advisory against the use of Qu Feng Huo Lou Dan, indicating it contains dexamethasone, a steroid that can harm users.

Why it matters

This warning is crucial as dexamethasone can weaken the immune system and lead to severe withdrawal symptoms; immediate action is advised for users.

Action needed

Consumers should consult healthcare professionals if using this product and report any adverse effects to FDA’s MedWatch Safety Information.

Relevant for
QPPVSignal Management LeadMedical Safety Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Aug 25, 2026

Full briefing

Practical implication

Consumers should consult healthcare professionals if using this product and report any adverse effects to FDA’s MedWatch Safety Information.

The FDA warns that Qu Feng Huo Lou Dan, promoted for pain relief, may contain dexamethasone not listed on the label, posing health risks.

What changed: The FDA has issued a consumer advisory against the use of Qu Feng Huo Lou Dan, indicating it contains dexamethasone, a steroid that can harm users.

Why it matters: This warning is crucial as dexamethasone can weaken the immune system and lead to severe withdrawal symptoms; immediate action is advised for users.

Practical implication: Consumers should consult healthcare professionals if using this product and report any adverse effects to FDA’s MedWatch Safety Information.

View original source

  • Source: FDA - What's New Drugs RSS
  • Published at source: 2026-08-25T00:00:00.000Z
  • Discovered by monitor: 2026-08-25T19:36:40.064Z

Published from the regulator source ingestion pipeline after PV impact triage.

#Safety Signal#Safety Signals#Source-ingestion#Regulator-monitor#Usa#Fda.gov

Related updates for your role

publicFDA · USA · Updated Aug 25, 2026

FDA Approves First Drug for Warm Autoimmune Hemolytic Anemia

Urgency: High

Healthcare providers and manufacturers must now comply with new reporting obligations for adverse reactions associated with the use of Imaavy and ensure adherence to increased compliance requirements for its administration.

LabelingSignal ManagementRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Labeling Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicFDA · USA · Updated Aug 25, 2026

Ongoing Accelerated Approvals for Infectious Disease Products

Urgency: High

Regulatory intelligence teams should review ongoing studies and compliance with postmarketing requirements for the drugs listed, specifically focusing on their deadlines for completion and the nature of the studies required.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicFDA · USA · Updated Aug 25, 2026

FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar

Urgency: High

Stakeholders should incorporate the device authorization into labeling and signal management protocols to ensure compliance and effective communication regarding its capabilities.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Labeling Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicFDA · USA · Updated Aug 25, 2026

Guidance on Use of Clove Oil as Anesthetic for Fish

Urgency: High

Regulatory intelligence teams must update workflows to exclude clove oil as an anesthetic for fish and ensure compliance with the guidance, including awareness of approved alternatives.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward